Pharmaceutical Intermediates Market to reach US$ 30 Billion, with the predicted to exhibit a CAGR of 4% during the forecast period 2020-2030

The rapidly increasing prevalence of chronic diseases around the world is expected to fuel the need for novel drugs and better treatment option would further drive the growth of the global market. Due to increasing demand for novel drugs option, there has been rising applications of drug intermediates and growing adoption and in the field of research and clinical studies.

Leading players in the biotechnology and pharmaceutical sectors along with research institutes are now increasingly focusing on R&D activities relating to drug creation and development. Future Market Insights (FMI) in a new study has forecast the global pharmaceutical intermediates to reach US$ 30 Bn in 2020, with the market predicted to exhibit a CAGR of 4% during the forecast period (2020-2030)

"To remain ‘ahead’ of your competitors, request for a sample" - https://www.futuremarketinsights.com/reports/sample/rep-gb-4515

Pharmaceutical intermediates are used in during manufacturing of bulk drugs as raw materials. These are the material produced during the synthesis of an active pharmaceutical ingredient (API). However, pharmaceutical and biotech companies can make use of these drug intermediates for the purposes of research and development (R&D). Moreover, there are different forms of pharmaceutical intermediates available such as high quality pharmaceutical intermediates, moderate quality pharmaceutical intermediates and premium quality intermediates. The high-quality and premium pharmaceutical intermediates are mainly used for R&D activities.

COVID-19 pandemic is negatively impacting pharmaceutical intermediates sales due to supply chain disruptions caused due to extended period of lockdown. Nonetheless growth is expected to recover because an increasing number of pharma companies are engaging in research and development to find effective treatment and vaccination for COVID-19 virus.

Key Takeaways from Pharmaceutical Intermediates Marker Study

The demand for chiral intermediates will continue rising through the forecast period
East Asia will dominate in the global pharmaceutical intermediates market. China is expected to emerge as the most lucrative market for pharmaceutical intermediates in the region.
Analgesics to remain primary application, expanding at Y-o-Y rate exceeding 6% through 2020
The demand for Generic Drug Intermediates is expected to be higher than Branded Drug Intermediates
Biotech and Pharma Companies will continue exhibiting high demand for pharmaceutical intermediates

“Rising drug development activities worldwide as well as increasing adaption of pharmaceutical intermediates as raw material are driving the growth of global Pharmaceutical Intermediates market” says the FMI Analyst

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/pharmaceutical-intermediates-market

Acquisitions, Partnerships and expansion are key Strategic Focus of Pharmaceutical Intermediates Market Players

Leading players in the Pharmaceutical Intermediates market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

On April 2018, strategic collaboration between Porton Pharma Solutions, Ltd. And Codexis, Inc. to use Codexis’ biocatalyst technology within Porton’s global custom active pharmaceutical ingredients (API) and intermediate for manufacturing business.
On June 2017, BASF SE is expanding its production capacity at Texas site, whereas it is also constructing new Ibuprofen API facility in Ludwigshafen, Germany, which is expected to be functional in 2021.

Key Participant Insights

The global market is set to expand its scope in the forecast period, due to rising prevalence of chronic disease globally and adoption of Pharmaceutical Intermediates at various stages of drug development by pharmaceutical manufacturers. In addition to this, cost effectiveness and rise in alternate methods for purification of oligonucleotide has augmented the sales of Pharmaceutical Intermediates.

The key market players covered by FMI include

Chiracon GmbH

Aceto Corporation,

Midas Pharma GmbH,

Codexis, Lianhe Chemical Technology Co., Ltd,

Sanofi S.A,

Dishman Group And BASF SE, And Chemcon Speciality Chemicals Pvt. Ltd

consolidating their positions through mergers, acquisitions and new product launches.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-4515

Enquiry before Buying

Is this research conducted by Future Market Insights?

Yes, the research has been conducted by expert analysts of Future Market Insights through a combination of primary research and secondary research. To know more about how the research was conducted, you can speak to research analyst.

What research methodology is followed by FMI?

FMI follows a methodology that encompasses demand side assessment of the market, and triangulates the same through supply side analysis. This methodology is based on use of standard market structure, methods and definitions Request detailed methodology.

Who are the respondents for primary research?

FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. For a full list of primary respondents, please reach out to us.

Pharmaceutical Intermediates Market - Key Segments

Product

Chemical Intermediates
Bulk Drug Intermediates
Chiral Intermediates
Achiral Intermediates
Custom Intermediates

Category

Branded Drug Intermediates
Generic Drug Intermediates

Application

Analgesics
Anti-inflammatory Drug
Cardiovascular Drugs
Anti-diabetic Drugs
Antimicrobial Drugs
Anti-cancer Drugs
Others

End User

Biotech and Pharma Companies
Research Laboratory
CMOs/CROs

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-4515

Region

North America
Latin America
Europe
East Asia
South Asia
Middle East and Africa (MEA)
Oceania

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

This release was published on openPR.